How much revenue does Anthera Pharmaceuticals make?

Anthera Pharmaceuticals reported $0 in revenue for fiscal year 2017, down 100.0% from $145,000 in fiscal year 2016. In Q1 2018 revenue was $0.

What companies are similar to Anthera Pharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Canntab Therapeutics Limited (CTABF), Evelo Biosciences, Inc. (EVLO), Ventura Cannabis & Wellness Corporation (CVHIF), Claritas Pharmaceuticals, Inc. (CLAZF).

Anthera Pharmaceuticals, Inc. (ANTH) Stock

About Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinic...

At a glance

Anthera Pharmaceuticals reported revenue of $0 for fiscal year 2017, down 100.0% from fiscal year 2016, and net income of -$29.38 million. In Q1 2018 (the quarter ended March 31, 2018) revenue was $0.

Figures from company filings; latest fiscal year ended December 31, 2017.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.